Amarin Targets Dr. Reddy's Over Vascepa Generic
By Kaitlyn Kiernan ( May 2, 2014, 3:43 PM EDT) -- Dr. Reddy's Laboratories Inc. was hit with a suit in New Jersey federal court Thursday alleging its proposed generic blood fat drug infringes on a host of Amarin Pharmaceuticals Ireland Ltd. patents for high blood fat treatment Vascepa....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.